The activity of netilmicin against a variety of bacteria was similar to that of gentamicin, sisomicin, and tobramycin, but it was less active than these three drugs against Pseudo.-nonas aeruginosa. Synergy with penicillin G against enterococci was demonstrated.
Netilmicin is a derivative of sisomicin by the addition of an ethyl radical at the 1-N position on the deoxystreptamine moiety. Preliminary animal studies by the manufacturer (Schering Corp.) suggest that threshold toxicity to kidney and vestibular apparatus occurs at a serum concentration up to five times that of gentamicin. Comparative studies of the in vitro antimicrobial activities of aminoglycosides have suggested that the parent compound sisomicin is equal in activity to, or more active than, gentamicin (1) (2) (3) All strains were tested against netilmicin, sisomicin, tobramycin, amikacin, and gentamicin. Minimum inhibitory concentrations were determined on Mueller-Hinton agar using the Steers multiple inoculator (6) and a broth inoculum containing 108 colony-forming units/ml. The antibiotic concentrations used were 0.2, 0.4, 0.8, 1.6, 3.0, 5.0, 8.0, 10.0, 15.0, and 20.0 ,ug/ ml. Cumulative percentages of susceptibility to the various antibiotic concentrations were plotted for each strain, and from these graphs were calculated the concentrations required to inhibit 50 and 90% of the strains.
Against E. coli, all five aminoglycosides exhibited almost identical activity with the exception of amikacin, which was slightly less active (Table 1) . Netilmicin and sisomicin equalled the activity of gentamicin against 50% of strains of Klebsiella spp. (Table 1 ). However, 98% of the Klebsiella strains tested were inhibited by 0.8 ,g of sisomicin per ml as compared to 1.6 ,ug each of netilmicin and gentamicin per ml.
Although the total number of strains of Enterobacter spp. and Citrobacter spp. (Table 1) was small, the results suggest that netilmicin and sisomicin were more active than the other antibiotics tested. There seemed little apparent difference between the activity of all five aminoglycosides against P. mirabilis (Table 1) , which is at variance with the fimdings of Levison and Kaye (2), who ascribed greater activity to gentamicin and sisomicin than to tobramycin and amikacin.
Netilmicin displayed significantly less activity than the other antibiotics against P. aeruginosa ( Table 2 ).
All strains ofS. aureus tested were inhibited by 0.2 ug of each antibiotic per ml, except amikacin, which required 3 ,ug/ml to inhibit 100% ofS. aureus strains. Netilmicin, sisomicin, and gentamicin showed activity against enterococcus (Table 1 ). In particular, at 10 ,ug/ml, 49% of strains were inhibited by netilmicin, whereas only 7% were inhibited by gentamicin; the other aminoglycosides were ineffective. This prompted an investigation of the synergistic activity of gentamicin (5 ,g/nml) and netilmicin (5 ,ug/ml), respectively, in combination with penicillin (20 ,ug/ml) against 15 strains ofStreptococcus faecalis and 1 strain of Streptococcus faecium. The method used was that of timed killing curves as described by Moellering et al. (4, 5) .
Synergy was demonstrated with both drug combinations against 14 of 15 strains of S. faecalis; the remaining strain was completely killed by gentamicin alone at 24 h. Synergy was demonstrated between penicillin and netilmicin against all strains ofS. faecalis and against the single strain ofS. faecium. One strain ofS. faecalis was particularly susceptible to genta- micin, so that synergy as defined (4, 5) could not be demonstrated at 24 h, but there was a 3-log difference in the number of surviving bacteria at 4 h when either combination was compared with the best single drug. As previously reported (1-3) , the activities of gentamicin, tobramycin, and sisomicin do not differ greatly from each other and netilmicin appears to follow a similar pattern of activity against aerobic gram-negative rods, but with the important difference that netilmicin is significantly less active against P. aeruginosa.
